Keyphrases
Antisense Oligonucleotides
100%
Viremia
100%
Hepatitis B Virus
100%
Antigenemia
100%
Hepatitis B Surface Antigen (HBsAg)
75%
Oligonucleotide Therapeutics
37%
Clinical Application
25%
Antisense
25%
Hydrodynamic Transfection
25%
Antigen Production
25%
Current Treatment
12%
Gene Expression
12%
Infected Cells
12%
Cell Culture
12%
Novel Therapeutics
12%
Antiviral Activity
12%
Clinical Setting
12%
Genotype
12%
Poor Prognosis
12%
Interferon-α (IFN-α)
12%
Nucleoside Analogues
12%
Transgenic
12%
Efficacy in Vivo
12%
Nucleosides
12%
Circulating Tumor DNA (ctDNA)
12%
Chronic HBV Infection
12%
Antigen Levels
12%
Nucleos(t)ide Analogues
12%
Transfection System
12%
Pan-genome
12%
Antisense Technology
12%
Liver-targeted Therapy
12%
Entecavir
12%
Chronic Hepatitis B Virus Infection
12%
HBV Infection Model
12%
Medicine and Dentistry
Hepatitis B Virus
100%
Viremia
100%
Antisense Oligonucleotide
100%
Membrane Antigen
46%
In Vitro
23%
Antisense
23%
Infection
15%
Hydrodynamics Based Transfection
15%
Gene Expression
7%
Cell Culture
7%
Interferon
7%
Targeted Therapy
7%
Antiviral Activity
7%
Nucleoside
7%
Chronic Hepatitis B
7%
Entecavir
7%
Nucleoside Analog
7%
Immunology and Microbiology
Antisense
100%
Hepatitis B Virus
100%
Viremia
100%
Membrane Antigen
46%
In Vitro
23%
Hydrodynamics Based Transfection
15%
Infection
15%
interferon
7%
Gene Expression
7%
Cell Culture
7%
Antiviral Activity
7%
Transgenics
7%
Hepatitis B
7%
Pharmacology, Toxicology and Pharmaceutical Science
Viremia
100%
Antisense Oligonucleotide
100%
Hepatitis B Virus
100%
Membrane Antigen
46%
Infection
15%
Cell Culture
7%
Antiviral Activity
7%
Interferon
7%
Lead Compound
7%
Nucleoside
7%
Chronic Hepatitis B
7%
Entecavir
7%
Nucleoside Analog
7%